|
|
||||||||
Neuroradiology |
1 From the Depts of Neuroradiology (T.N., W.G., U.S., U.K., D.S., I.M., J.M., K.V.), General Surgery (R.V., W.L.), and Gastroenterology and Hepatology (S.K., M.G.), Univ of Tübingen, Hoppe-Seyler Str. 3, 72076 Tübingen, Germany. Received Apr 26, 1999; revision requested Jul 12; final revision received Jan 24, 2000; accepted Mar 7. Supported in part by the Deutsche Forschungsgemeinschaft (DFG: KL 1093/1-1). U.K. supported by a grant from the Federal Ministry of Education Science, Research and Technology (Foe. 01KS9602). T.N. supported by the Interdisciplinary Clinical Research Center (IKFZ), Tübingen. Address correspondence to T.N. (e-mail: thomas.naegele@med.uni-tuebingen.de).
PURPOSE: To evaluate changes in hydrogen 1 magnetic resonance (MR) spectroscopic findings in overt or subclinical hepatic encephalopathy (HE) after liver transplantation and to compare these changes with clinical outcomes and basal ganglia high signal intensity (BGH).
MATERIALS AND METHODS: Twenty-two patients scheduled for liver transplantation and 17 healthy control subjects were examined with 1H MR spectroscopy and standard nonenhanced MR imaging. Eight patients underwent complete MR imaging and 1H spectroscopic examinations before liver transplantation and at 34-week, 1228-week, and 1012-month follow-up after liver transplantation.
RESULTS: Before liver transplantation, typical 1H spectroscopic changesdecreased myo-inositol (mI)/creatine (Cr) and choline (Cho)/Cr ratios and an elevated glutamine and glutamate (Glx)/Cr ratiowere found in 21 patients. Eighteen patients had BGH at T1-weighted imaging. Three to 7 months after liver transplantation, the mI/Cr and Glx/Cr ratios were within the normal range in five of eight and eight of eight patients, respectively, without any residual signs of subclinical or overt HE; however, at MR imaging, seven patients still had BGH.
CONCLUSION: After successful liver transplantation, renormalization of HE-specific brain metabolite changes is detected at 1H spectroscopy and precedes the disappearance of BGH. The neuropsychologic signs of subclinical or overt HE follow the changes seen at 1H spectroscopy rather than those seen at MR imaging.
Index terms: Brain, diseases, 10.59, 10.891 Brain, metabolism Brain, MR, 10.121411, 10.121416, 10.12145 Liver, cirrhosis, 761.79 Liver transplantation, 761.45, 761.79 Magnetic resonance (MR), spectroscopy, 10.12145, 18.12145
This article has been cited by other articles:
![]() |
E. Matsusue, T. Kinoshita, E. Ohama, and T. Ogawa Cerebral Cortical and White Matter Lesions in Chronic Hepatic Encephalopathy: MR-Pathologic Correlations AJNR Am. J. Neuroradiol., February 1, 2005; 26(2): 347 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. da Rocha, F. T. Braga, C. J. da Silva, A. C. M. Maia Jr, G. S. Mourao, and R. J. Gagliardi Reversal of Parkinsonism and Portosystemic Encephalopathy Following Embolization of a Congenital Intrahepatic Venous Shunt: Brain MR Imaging and 1H Spectroscopic Findings AJNR Am. J. Neuroradiol., August 1, 2004; 25(7): 1247 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mattarozzi, A. Stracciari, L. Vignatelli, R. D'Alessandro, M. C. Morelli, and M. Guarino Minimal Hepatic Encephalopathy: Longitudinal Effects of Liver Transplantation Arch Neurol, February 1, 2004; 61(2): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takanashi, A. Kurihara, M. Tomita, M. Kanazawa, S. Yamamoto, F. Morita, H. Ikehira, S. Tanada, and Y. Kohno Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency Neurology, July 23, 2002; 59(2): 210 - 214. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |